That’s the question many scientists will ask once they see what the new Octet® R8e BLI system can do. It delivers near-SPR sensitivity with the flexibility, speed, and simplicity of BLI, offering deeper insights, faster decisions, and fewer compromises in discovery and development.
Explore how the R8e is bridging the sensitivity gap for good.
Unlock a world of limitless opportunities in digital transformation with LabVantage Solutions. Their expanding state-of-the-art informatics platform helps to deliver smart problem-solving solutions tailored to tackle complex data challenges with an operational edge. Partner with LabVantage Solutions to explore how they are helping organizations to achieve excellence in digital transformation.
65LAB has awarded US$1.5 million (approx. S$1.9 million) to Professor Enrico Petretto to advance a breakthrough drug discovery platform developed at Duke-NUS Medical School. The project aims to deliver first-in-class antifibrotic therapies for lung and kidney diseases-conditions that currently have no effective treatment.
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment.
In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID.
An international research team led by the University of Vienna has succeeded in developing a new method to directly measure partial charges in molecules. The results, now published in Nature, provide new insights into molecular interactions and offer potential applications in drug development and materials science.
How would you rate today's newsletter?
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of
our websites
and requested to be notified of additional information.
__638907652076425247_multisizecolor_0_custom.jpg)
